SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-09-001009
Filing Date
2009-04-03
Accepted
2009-04-02 19:33:08
Documents
7
Period of Report
2009-05-21
Effectiveness Date
2009-04-03

Document Format Files

Seq Description Document Type Size
1 EMERGENT BIOSOLUTIONS INC. w73421def14a.htm DEF 14A 623486
2 GRAPHIC w73421w7342100.gif GRAPHIC 3030
3 GRAPHIC w73421w7342101.gif GRAPHIC 716
4 GRAPHIC w73421w7342122.gif GRAPHIC 2471
5 GRAPHIC w73421w7342103.jpg GRAPHIC 247607
6 GRAPHIC w73421w7342104.jpg GRAPHIC 298200
7 GRAPHIC w73421w7342105.jpg GRAPHIC 306301
  Complete submission text file 0000950133-09-001009.txt   1808419
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33137 | Film No.: 09729617
SIC: 2834 Pharmaceutical Preparations